(Date:2/8/2010)... , Feb. 8 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,Inc. (the "Company") (Nasdaq: CMED ), ... the,following investor conferences in March 2010 : , , Investor Conference ... Location, Rodman & Renshaw Annual ... China Investment ... Beijing, Conference, Credit Suisse ...
(Date:2/8/2010)... Full enrollment occurs five months ahead of schedule ,, ... /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix" or the "Company") ... the Phase 2 clinical study of its lead drug ... ASSERT trial, a full 5 months ahead of our ... staff and our collaborators at the Cleveland Clinic. At ...
(Date:2/8/2010)... announced today that it has been selected by Invida Group, ... Pacific, to develop and execute its corporate communications and public ... ... (Vocus) February 8, 2010 -- LaVoie Group , a ... been selected by Invida Group , the leading provider ...
(Date:2/8/2010)... has hired Lisa Wichman and Sahar Meyer to its expanding staff of ... and will focus on key healthcare markets in the Northeast. Ms. Meyer ... NE. , ... Foothill Ranch, CA (Vocus) February 8, 2010 -- ... a new Account Manager and Manager of Analytics. , ,Lisa Wichman joins ...
Breaking Biology Technology:China Medical Technologies to Participate Investor Conferences in March 2010 2Resverlogix Completes Patient Recruitment for ASSERT Trial 2Resverlogix Completes Patient Recruitment for ASSERT Trial 3Resverlogix Completes Patient Recruitment for ASSERT Trial 4Invida Selects LaVoie Group as Public Relations Agency of Record 2Invida Selects LaVoie Group as Public Relations Agency of Record 3Healthcare Data Solutions Announces Expansion of its Healthcare Customer Solutions Team With Two Key Additions 2Healthcare Data Solutions Announces Expansion of its Healthcare Customer Solutions Team With Two Key Additions 3... 5 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq:,ONTY) (TSX: ONY), ... therapeutic products for the treatment of cancer, today,announced ... http://www.oncothyreon.com ., "We are excited about ... updated website, which provides additional information about our,product ...
... PLEASANTON, Calif., Feb. 5 Thoratec,Corporation (Nasdaq: THOR ... today reported results for the fourth quarter and,twelve months ... December 29, 2007, Thoratec Corporation,reported revenues of $234.8 million, ... in fiscal 2006. Revenues for the fourth quarter,of fiscal ...
... YORK, Feb. 5 Keryx Biopharmaceuticals,Inc. (Nasdaq: KERX ) ... Executive Officer, will be presenting at the following,upcoming Investor Conferences:, ... Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical,Device Conference, ... Monday, February 11, 2008 - 12:30 PM ET: ...
Other Biology Technology:Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 2Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 3Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 4Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 5Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 6Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 7Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 8Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 9Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 10Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 11Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 12Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 13Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 14Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 15Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History 16Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations 2... Dithiothreitol DTT ... GAS. Purity: ≥99% by ... Absorbance: (100 mM, ... in EtOH or H 2 ...
... S. pombe Whole Genome ChIP-on-chip Microarray ... of yeast (S. pombe) DNA binding ... with Agilent DNA microarrays. This set ... data with greater true binding events ...
... Salmonella genomes has allowed the development of ... pairs. The S. enterica Typhimurium (strain LT2) ... bp; 4,440 ORFs) and a plasmid, pSLT ... Sigma-Genosys have been designed to amplify all ...
... stacker system, offers fast and reliable batch ... , Ultra Evolution , SAFIRE monochromator reader ... Plus , LS Series of Laser Scanners ... wide range of detection and separation systems, ...
Biology Products:Biology NavigationMedical Navigation